Innovation1 Biotech
Our Approach
Evidence-Based Methodology
Our scientific approach integrates comprehensive metabolic assessment with personalized nutritional intervention. We employ advanced diagnostic protocols to identify specific physiological imbalances that may benefit from targeted nutritional support. This methodology enables us to address metabolic dysregulation with precision and clinical rigor.
Diagnostic Assessment Protocol
Our clinical team specializes in the application of advanced diagnostic panels that provide detailed analysis of metabolic function, nutritional status, hormone balance, and cellular energetics. These assessments are particularly relevant for patients experiencing post-COVID sequelae and cognitive function concerns. Our comprehensive panels evaluate:
Metabolic pathway functionality
Oxidative stress markers
Mitochondrial function indicators
Nutritional status assessment
Hormonal balance evaluation
Clinical Assessment
Process
Upon receiving diagnostic results, our team conducts comprehensive biomarker analysis using proprietary assessment algorithms developed under Dr. Arad’s scientific direction. This systematic approach identifies specific patterns of metabolic dysfunction, hormone imbalances, inflammatory activation, mitochondrial impairment, and nutritional deficiencies. Our assessment process correlates objective biomarker findings with clinical presentation, establishing documented evidence of specific nutritional requirements resulting from physiological dysfunction
Personalized Medical Food Development
Based on comprehensive clinical assessment findings, we develop personalized medical food specifications addressing documented nutritional requirements. These formulations adhere to strict quality control protocols, ensuring each product meets FDA requirements for medical foods under 21 CFR 101.9(j)(8). Our specialized manufacturing capabilities enable precise calibration of bioactive compounds targeted to specific metabolic pathways identified through our diagnostic assessments.